Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Wellcome Trust Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Oxford Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Manchester Featured PhD Programmes

FGFR signalling in breast cancer


Project Description

Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate. This is particularly true of the Fibroblast growth factors (FGFs), whose signals are critical for the development of many organs. Since FGFs provide powerful growth signals, their signalling pathway is tightly regulated. However, some cancer cells hijack this pathway to gain a growth advantage over normal cells. FGFs and their receptors, FGFR1 and FGFR2, have been implicated in cancer susceptibility and progression (i.e breast, cervical, endometrial, prostate, lung cancer), suggesting that FGF signalling may be co-opted by cancer cells. FGFRs signal from the cell membrane and from endosomal compartments via MAPK, PI3K, PLC-gamma and STATs. However, there is evidence that other tyrosine kinase receptors as well as full-length FGFRs, and FGFR1 in particular, can be targeted to the nucleus.

We previously showed that a C-terminal fragment of FGFR1, traffics to the nucleus and regulates the expression of target genes. We confirmed Granzyme B (GrB) as the protease that mediates cleavage and showed that GrB inhibition blocks specific FGF-dependent effects. We demonstrated that this phenomenon also occurs in vivo in invasive breast cancer and have identified a panel of FGFR1-regulated target genes, all of which regulate cell migration likely reflecting an invasive signature (Chioni and Grose 2012). Thus we described a novel mechanism by which FGF signalling can regulate cancer cell behaviour, and suggest a novel therapeutic target for treatment of invasive breast cancer. We showed that endogenous GrB plays a promigratory role, at least in part through cleaving FGFR1.

This proposed project is a natural progression from our previous studies and is based on two key findings regarding FGFR signalling in breast, pancreatic cancer (Coleman, Chioni et al., 2014; Chioni and Grose, 2012) as well as preliminary data on cervical cancer (unpublished data):
(I) FGFR1 translocates to the nucleus upon stimulation with its ligand and this is correlated with metastatic cell behaviours both in 2D cell culture and 3D organotypic culture model, as well as in human patients.
(II) We have identified in breast cancer a novel mechanism that FGFR1 gets cleaved by Granzyme B (GrB) and the C-terminus portion of FGFR1 then translocates to the nucleus and acts as a transcription factor that regulates various target genes (Chioni and Grose, 2012).

Main aims

1. Determine the importance of ligand/receptor interaction in FGFR1 nuclear localisation and hence cancer progression.
2. Investigate whether full length FGFR1 is also translocated to the nucleus.
3. Investigate whether FGFR1 kinase activity is required for nuclear FGFR1 localisation and/or target gene regulation.
4. Investigate further the FGFR1 target genes

The potential PhD student will become proficient in a wide range of cellular and molecular techniques (e.g. Western blots, PCR, overexpression of FGFR(s), RNAi, functional studies such as proliferation, migration, invasion, organotypic modelling) that will be used to answer important scientific questions relating to cell signalling and cancer.

Funding Notes

No funding is available - only self-funded applications can be considered

References

Coleman SJ, Bruce C, Chioni AM, Kocher HM, Grose RP. (2014) The ins and outs of fibroblast growth factor receptor signaling. Clin Sci 127 (4): 217-31

Stacey J Coleman, Athina-Myrto Chioni, Mohammed Ghallab, Rhys K Anderson, Nicholas R Lemoine, Richard P Grose, Hemant M Kocher (2014) ‘Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells is necessary for pancreatic cancer cell invasion’ EMBO Molecular Medicine (accepted).

Chioni AM, Grose R (2012) FGFR1 cleavage and nuclear translocation regulates breast cancer cell behaviour. Journal of Cell Biology. 197(6):801-17

Chioni A-M, Grose R. (2008). Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis. Fibrogenesis & Tissue Repair. 1:8

How good is research at Kingston University in Allied Health Professions, Dentistry, Nursing and Pharmacy?

FTE Category A staff submitted: 17.22

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2018
All rights reserved.